Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

  • 1 December 2023 to 30 September 2024
  • Awards: Pump-priming Awards

The outer layer of the heart, the epicardium, plays key roles in cardiac formation and repair, promoting cardiomyocyte proliferation and vessel growth in developing embryos and in species that regenerate their hearts. The epicardium is maximally active for only a short window during development. Thereafter, it downregulates characteristic genetic markers, ceases to proliferate and to invade the myocardium, and undergoes morphological change, depicting the onset of epicardial quiescence during the perinatal period. We will delineate the mechanisms that drive quiescence in the murine epicardium, with the aim of identifying molecular switches that could be targeted to restore embryonic activity to the adult epicardium. To assess translational relevance, we will develop a human iPSC-derived epicardioid model and demonstrate the feasibility of such a system to investigate and manipulate quiescence in vitro.

The transcriptomic changes that accompany the transition to quiescence will be profiled by integrated scRNA-seq across the developmental time course.

The transcriptomic changes that accompany the transition to quiescence will be profiled by integrated scRNA-seq across the developmental time course.

Image Credit: Lupu, Redpath & Smart. bioRxiv 2021.11.25.470003; doi: https://doi.org/10.1101/2021.11.25.470003